US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
AbstractThe report covers forecast and analysis for the blood transfusion diagnostics market on a global and regional level. The study provides historic data for 2015, 2016, 2017 along with a forecast from 2018 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the blood transfusion diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the blood transfusion diagnostics market on a global level. In order to give the users of this report a comprehensive view on the blood transfusion diagnostics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. The study provides a decisive view on the blood transfusion diagnostics market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025. On the basis of product type, global blood transfusion diagnostics market is divided into kits and reagents, filtration systems, services, and others. Among these kits and reagents segment was the highest revenue grosser in 2017. On the basis of application, the market is divided into blood grouping and disease screening. The end-user segment includes hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks and hospitals dominated the market and accounted for the largest share in 2017. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S. Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for blood transfusion diagnostics based on individual segment and applications in all the regions and countries. Some of the key players in blood transfusion diagnostics market include BAG Health Care GmbH, Grifols, S.A., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, DiaSorin S.p.A., Immucor, Inc., Quotient Limited, Hologic, Inc. and Ortho Clinical Diagnostics. This report segments the global blood transfusion diagnostics market as follows: Global Blood Transfusion Diagnostics Market: Product Type Segment Analysis Instruments and Kits Reagents Others Global Blood Transfusion Diagnostics Market: Application Segment Analysis Blood Grouping Disease Screening Global Blood Transfusion Diagnostics Market: End-user Segment Analysis Hospitals Diagnostic Laboratories Blood Banks Plasma Fractionation Companies Global Blood Transfusion Diagnostics Market: Regional Segment Analysis North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Blood Transfusion Diagnostics Market, 2015 - 2025 (USD Billion) 2.2. Global Blood Transfusion Diagnostics Market: Snapsh | read more...